Cargando…

Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia

BACKGROUND: This study was to research the efficacy of fenofibrate in the treatment of microalbuminuria in the patients with type 2 diabetes mellitus (T2DM) and hypertriglyceridemia. METHODS: Type 2 diabetic patients (56) with microalbuminuria and hypertriglyceridemia aged 30 to 75 were randomly div...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaomeng, Liu, Jia, Wang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245839/ https://www.ncbi.nlm.nih.gov/pubmed/32446306 http://dx.doi.org/10.1186/s12944-020-01254-2

Ejemplares similares

PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2016)

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2015)

Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia
por: Poruba, Martin, et al.
Publicado: (2019)

PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study
por: Feng, Xiaomeng, et al.
Publicado: (2017)

PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance
por: Liu, Jia, et al.
Publicado: (2016)

Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
por: Ezhov, Marat V., et al.
Publicado: (2023)

Hypertriglyceridemia‐induced pancreatitis after egg retrieval for in vitro fertilization and fenofibrate cessation
por: Shrimanker, Tushaar V., et al.
Publicado: (2022)

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes
por: HU, ZHI-JUAN, et al.
Publicado: (2014)

Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes
por: Alonso-Villaverde, Carlos, et al.
Publicado: (2009)

Retinopathy and microalbuminuria in type II diabetic patients
por: Manaviat, Masoud R, et al.
Publicado: (2004)

Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting
por: Furat, Cevdet, et al.
Publicado: (2017)

TNF-α and Microalbuminuria in Patients with Type 2 Diabetes Mellitus
por: Lampropoulou, I.-Th., et al.
Publicado: (2014)

Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus
por: Sana, Muhammad Ahsan, et al.
Publicado: (2020)

Additional Treatment with Fenofibrate for Patients Treated with Pitavastatin Under Ordinary Medical Practice for Hypertriglyceridemia in Japan (APPROACH-J Study)
por: Wakida, Yasushi, et al.
Publicado: (2011)

Correlation between Microalbuminuria and Hypertension in Type 2 Diabetic Patients
por: Ali, Alia, et al.
Publicado: (2014)

Fenofibrate and Impaired Taste Perception in Type 2 Diabetes
por: Davis, Timothy M.E.
Publicado: (2020)

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Association of serum high-density lipoprotein cholesterol with microalbuminuria in type 2 diabetes patients
por: Sun, Xun, et al.
Publicado: (2018)

Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 2007;30:1581–1583
Publicado: (2013)

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
por: Frazier, Rebecca, et al.
Publicado: (2018)

A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
por: Chen, Haibing, et al.
Publicado: (2012)

The Correlation between Microalbuminuria and Thyroid Nodules in Type 2 Diabetic Mellitus
por: Cao, Can, et al.
Publicado: (2022)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
por: Reinhard, Henrik, et al.
Publicado: (2011)

Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients
por: Afkhami-Ardekani, M., et al.
Publicado: (2008)

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
por: Currie, Gemma E., et al.
Publicado: (2018)

Incidence of Microalbuminuria and Factors Affecting It in Patients With Type 2 Diabetes Mellitus
por: Khan, Tayyab Mumtaz, et al.
Publicado: (2022)

The Association Of Serum Cortisol Level With Microalbuminuria In Patients With Type 2 Diabetes And Prediabetes
por: Zhang, Xiaodan, et al.
Publicado: (2020)

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
por: Ficociello, Linda H., et al.
Publicado: (2009)

Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications
por: Ahmad, Tauseef, et al.
Publicado: (2017)

Serum osteoinductive factor is associated with microalbuminuria and diabetic nephropathy in type 2 diabetes
por: Wei, Wen, et al.
Publicado: (2018)

Effect of taurine and acetylcysteine in attenuating microalbuminuria in type 2 diabetes
por: Viswanathan, V., et al.
Publicado: (2008)

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
por: Feher, Michael, et al.
Publicado: (2013)

Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model
por: Shi, Tianshu, et al.
Publicado: (2017)

Circulating Vascular Progenitor Cells in Patients With Type 1 Diabetes and Microalbuminuria
por: Dessapt, Cecile, et al.
Publicado: (2010)

Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol‐3‐phosphate dehydrogenase 1 deficiency
por: Matarazzo, Lorenza, et al.
Publicado: (2020)

Assessment of microalbuminuria and albumin creatinine ratio in patients with type 2 diabetes mellitus
por: Karar, Tarig, et al.
Publicado: (2015)

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
por: Hiyoshi, Toru, et al.
Publicado: (2019)

Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients
por: Barbieri, Michelangela, et al.
Publicado: (2016)

Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria
por: Papazafiropoulou, Athanasia, et al.
Publicado: (2010)

Homocysteine as a Risk Factor for Development of Microalbuminuria in Type 2 Diabetes
por: Cho, Eun-Hee, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uaif15ltg0rtic9jij8d75kaco